Effect of statin therapy on mortality from infection and sepsis: A meta-analysis of randomized and observational studies

You Dong Wan, Tong Wen Sun, Quan Cheng Kan, Fangxia Guan, Shu Guang Zhang

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Introduction: Observational data have suggested that statin therapy may reduce mortality in patients with infection and sepsis; however, results from randomized studies are contradictory and do not support the use of statins in this context. Here, we performed a meta-analysis to investigate the effects of statin therapy on mortality from infection and sepsis.Methods: We searched electronic databases (PubMed and Embase) for articles published before November 2013. Randomized or observational studies reporting the effects of statin therapy on mortality in patients with infection or sepsis were eligible. Randomized and observational studies were separately pooled with relative risks (RRs) and random-effects models.Results: We examined 5 randomized controlled trials with 867 patients and 27 observational studies with 337,648 patients. Among the randomized controlled trials, statins did not significantly decrease in-hospital mortality (RR, 0.98; 95% confidence interval (CI), 0.73 to 1.33) or 28-day mortality (RR, 0.93; 95% CI, 0.46 to 1.89). However, observational studies indicated that statins were associated with a significant decrease in mortality with adjusted data (RR, 0.65; 95% CI, 0.57 to 0.75) or unadjusted data (RR, 0.74; 95% CI, 0.59 to 0.94).Conclusions: Limited evidence suggests that statins may not be associated with a significant reduction in mortality from infection and sepsis. Although meta-analysis from observational studies showed that the use of statins was associated with a survival advantage, these outcomes were limited by high heterogeneity and possible bias in the data. Therefore, we should be cautious about the use of statins in infection and sepsis.

Original languageEnglish (US)
Article numberR71
JournalCritical Care
Volume18
Issue number2
DOIs
StatePublished - Apr 11 2014
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Observational Studies
Meta-Analysis
Sepsis
Mortality
Infection
Confidence Intervals
Therapeutics
Randomized Controlled Trials
Hospital Mortality
PubMed
Databases
Survival

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Medicine(all)

Cite this

Effect of statin therapy on mortality from infection and sepsis : A meta-analysis of randomized and observational studies. / Wan, You Dong; Sun, Tong Wen; Kan, Quan Cheng; Guan, Fangxia; Zhang, Shu Guang.

In: Critical Care, Vol. 18, No. 2, R71, 11.04.2014.

Research output: Contribution to journalArticle

Wan, You Dong ; Sun, Tong Wen ; Kan, Quan Cheng ; Guan, Fangxia ; Zhang, Shu Guang. / Effect of statin therapy on mortality from infection and sepsis : A meta-analysis of randomized and observational studies. In: Critical Care. 2014 ; Vol. 18, No. 2.
@article{ba1981dcae5c47159f8f6189e0f87224,
title = "Effect of statin therapy on mortality from infection and sepsis: A meta-analysis of randomized and observational studies",
abstract = "Introduction: Observational data have suggested that statin therapy may reduce mortality in patients with infection and sepsis; however, results from randomized studies are contradictory and do not support the use of statins in this context. Here, we performed a meta-analysis to investigate the effects of statin therapy on mortality from infection and sepsis.Methods: We searched electronic databases (PubMed and Embase) for articles published before November 2013. Randomized or observational studies reporting the effects of statin therapy on mortality in patients with infection or sepsis were eligible. Randomized and observational studies were separately pooled with relative risks (RRs) and random-effects models.Results: We examined 5 randomized controlled trials with 867 patients and 27 observational studies with 337,648 patients. Among the randomized controlled trials, statins did not significantly decrease in-hospital mortality (RR, 0.98; 95{\%} confidence interval (CI), 0.73 to 1.33) or 28-day mortality (RR, 0.93; 95{\%} CI, 0.46 to 1.89). However, observational studies indicated that statins were associated with a significant decrease in mortality with adjusted data (RR, 0.65; 95{\%} CI, 0.57 to 0.75) or unadjusted data (RR, 0.74; 95{\%} CI, 0.59 to 0.94).Conclusions: Limited evidence suggests that statins may not be associated with a significant reduction in mortality from infection and sepsis. Although meta-analysis from observational studies showed that the use of statins was associated with a survival advantage, these outcomes were limited by high heterogeneity and possible bias in the data. Therefore, we should be cautious about the use of statins in infection and sepsis.",
author = "Wan, {You Dong} and Sun, {Tong Wen} and Kan, {Quan Cheng} and Fangxia Guan and Zhang, {Shu Guang}",
year = "2014",
month = "4",
day = "11",
doi = "10.1186/cc13828",
language = "English (US)",
volume = "18",
journal = "Critical Care",
issn = "1466-609X",
publisher = "Springer Science + Business Media",
number = "2",

}

TY - JOUR

T1 - Effect of statin therapy on mortality from infection and sepsis

T2 - A meta-analysis of randomized and observational studies

AU - Wan, You Dong

AU - Sun, Tong Wen

AU - Kan, Quan Cheng

AU - Guan, Fangxia

AU - Zhang, Shu Guang

PY - 2014/4/11

Y1 - 2014/4/11

N2 - Introduction: Observational data have suggested that statin therapy may reduce mortality in patients with infection and sepsis; however, results from randomized studies are contradictory and do not support the use of statins in this context. Here, we performed a meta-analysis to investigate the effects of statin therapy on mortality from infection and sepsis.Methods: We searched electronic databases (PubMed and Embase) for articles published before November 2013. Randomized or observational studies reporting the effects of statin therapy on mortality in patients with infection or sepsis were eligible. Randomized and observational studies were separately pooled with relative risks (RRs) and random-effects models.Results: We examined 5 randomized controlled trials with 867 patients and 27 observational studies with 337,648 patients. Among the randomized controlled trials, statins did not significantly decrease in-hospital mortality (RR, 0.98; 95% confidence interval (CI), 0.73 to 1.33) or 28-day mortality (RR, 0.93; 95% CI, 0.46 to 1.89). However, observational studies indicated that statins were associated with a significant decrease in mortality with adjusted data (RR, 0.65; 95% CI, 0.57 to 0.75) or unadjusted data (RR, 0.74; 95% CI, 0.59 to 0.94).Conclusions: Limited evidence suggests that statins may not be associated with a significant reduction in mortality from infection and sepsis. Although meta-analysis from observational studies showed that the use of statins was associated with a survival advantage, these outcomes were limited by high heterogeneity and possible bias in the data. Therefore, we should be cautious about the use of statins in infection and sepsis.

AB - Introduction: Observational data have suggested that statin therapy may reduce mortality in patients with infection and sepsis; however, results from randomized studies are contradictory and do not support the use of statins in this context. Here, we performed a meta-analysis to investigate the effects of statin therapy on mortality from infection and sepsis.Methods: We searched electronic databases (PubMed and Embase) for articles published before November 2013. Randomized or observational studies reporting the effects of statin therapy on mortality in patients with infection or sepsis were eligible. Randomized and observational studies were separately pooled with relative risks (RRs) and random-effects models.Results: We examined 5 randomized controlled trials with 867 patients and 27 observational studies with 337,648 patients. Among the randomized controlled trials, statins did not significantly decrease in-hospital mortality (RR, 0.98; 95% confidence interval (CI), 0.73 to 1.33) or 28-day mortality (RR, 0.93; 95% CI, 0.46 to 1.89). However, observational studies indicated that statins were associated with a significant decrease in mortality with adjusted data (RR, 0.65; 95% CI, 0.57 to 0.75) or unadjusted data (RR, 0.74; 95% CI, 0.59 to 0.94).Conclusions: Limited evidence suggests that statins may not be associated with a significant reduction in mortality from infection and sepsis. Although meta-analysis from observational studies showed that the use of statins was associated with a survival advantage, these outcomes were limited by high heterogeneity and possible bias in the data. Therefore, we should be cautious about the use of statins in infection and sepsis.

UR - http://www.scopus.com/inward/record.url?scp=84899937720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899937720&partnerID=8YFLogxK

U2 - 10.1186/cc13828

DO - 10.1186/cc13828

M3 - Article

C2 - 24725598

AN - SCOPUS:84899937720

VL - 18

JO - Critical Care

JF - Critical Care

SN - 1466-609X

IS - 2

M1 - R71

ER -